Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;28(2):410-420.
doi: 10.1177/1078155221995539. Epub 2021 Feb 23.

The safe handling of chemotherapy drugs in low- and middle-income countries: An overview of practices

Affiliations

The safe handling of chemotherapy drugs in low- and middle-income countries: An overview of practices

Sandrine von Grünigen et al. J Oncol Pharm Pract. 2022 Mar.

Abstract

Introduction: The rising burden of cancer in low- and middle-income countries (LMICs) has led to substantial efforts to improve access to chemotherapy. The present study's objectives were to obtain an overview of the safe handling practices implemented in LMICs' healthcare facilities when dealing with chemotherapy drugs and to prioritize opportunities for improving them.

Methods: We conducted an online survey, from June 2018 to April 2019, among LMIC healthcare facilities dealing with chemotherapy drugs. Facilities were asked to self-assess their chemotherapy handling processes using Cyto-SAT, a self-assessment tool incorporating 134 items organized into 10 domains (management, personnel, logistics, prescription, preparation, administration, incident management, waste management, cleaning, and patient counselling). Data were recorded on an online platform (www.datapharma.ch/cyto-SAT).

Results: The survey enrolled 53 healthcare facilities (15 from low-income, 26 from lower-middle-income, and 12 from upper-middle-income countries). The median level of implementation of safe practices was 63% (Q1:39%-Q3:77%). Facilities in low-income countries (LICs) reported lower median levels of safe practices than middle-income countries (MICs) [LICs: 32% (Q1:24%-Q3:62%), Lower-MICs: 63% (Q1:49%-Q3:70%), Upper-MICs: 85% (Q1:77%-Q3:93%)]. The biggest differences between country categories were observed in the domains related to personnel, preparation processes, and incident management.

Conclusion: This overview of practices highlighted a large variability and major gaps in the safe handling of chemotherapy drugs in LMICs. Improvement strategies are needed to increase patient and staff safety and limit environmental contamination, especially in LICs. Safe handling programs should be part of continuing efforts to improve access to quality cancer drugs and should be integrated into national cancer control programs.

Keywords: Safe handling practices; chemotherapy; cytotoxic drugs; low- and middle-income countries; oncology.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Study flow diagram.
Figure 2.
Figure 2.
Geographical locations of included survey participants.
Figure 3.
Figure 3.
Median percentage level of implementation of safe practices, by domain.
Figure 4.
Figure 4.
Median percentage of implementation of safe handling practices for the preparation sub-domain.

Similar articles

Cited by

References

    1. Connor T, MacKenzie B, DeBord D, et al.. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings. National Institute for Occupational Safety and Health, Department of Health and Human Services, Centers for Disease Control and Prevention, www.cdc.gov/niosh/docs/2016-161/pdfs/2016-161.pdf (2016, accessed 8 February 2017).
    1. Connor TH, Burroughs G, McDiarmid M, et al.. NIOSH alert: preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Atlanta, GA: DHHS NIOSH, 2004, pp.1–50.
    1. Phillips J, Beam S, Brinker A, et al.. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 2131–2131. - PubMed
    1. Greenall J, Shastay A, Vaida AJ, et al.. Establishing an international baseline for medication safety in oncology: findings from the 2012 ISMP international medication safety self assessment® for oncology. J Oncol Pharm Pract 2015; 21: 26–35. - PubMed
    1. ASHP Council on Professional Affairs. ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health-Syst Pharm 2002; 59: 1648–1668. - PubMed

Substances